StockTipsArenaBeta

BUY Gland Pharma Limited — Nomura India Research

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byNomura India ResearchHorizon: NA (inferred 1 year)7 Oct 2026via CNBC Awaaz.

Entry₹3,026Inferred
Target₹3,750
Total upside +23.93%
Stop lossNot given
CMP₹3,079.13h ago
Active+1.75%+21.79%upside left 12 mo left
Follow Nomura India Research for new calls(100% target hit, 17 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 7 other Long-term calls on GLANDSee 105 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:55 pm IST
24 supporting10 neutral5 opposing
Supports the BUY call (24)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·7 Oct · yesterday

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·7 Oct · yesterday

5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·5 Oct · 3d ago

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

NewsCnbc-Tv18·1 Oct · 1w ago

(opens in new tab)

Gland Pharma Ltd acquired Gland Pharma USA Inc., a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd.

BSE · Company Update·13 Sept · 4w ago

(opens in new tab)
Neutral / worth noting (10)

Gland Pharma Limited's Board approved the acquisition of 100% equity share capital of Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd. This move aims to streamline the corporate structu

NSE · Outcome of Board Meeting·13 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (5)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·12 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Nomura India Research

Every call and its outcome